Review Article, J Virol Antivir Res Vol: 1 Issue: 2
Towards a West Nile Virus Vaccine
Jared D Evans* | |
University of Pittsburgh, Pittsburgh, USA | |
Corresponding author : Dr. Jared D Evans Assistant Professor, Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA Tel: (412) 648-7400 E-mail: evansj2@cvr.pitt.edu |
|
Received: June 22, 2012 Accepted: September 05, 2012 Published: October 31, 2012 | |
Citation: Evans JD (2012) Towards a West Nile Virus Vaccine. J Virol Antivir Res 1:2. doi:10.4172/2324-8955.1000101 |
Abstract
Towards a West Nile Virus Vaccine
West Nile virus (WNV) is a significant mosquito-borne human pathogen belonging to the Flaviviridae family with dengue, yellow fever, and Japanese encephalitis viruses. Recently, WNV has emerged as an important public health concern in the Western hemisphere, where it has established an endemic zoonotic cycle. Outcomes of WNV infection range from benign, non-symptomatic infection to flu-like febrile illness to severe central nervous system (CNS) manifestations.